RECRUITINGINTERVENTIONAL

Double Voiding and Post-transplant UTI

A Randomized Trial of Double Voiding Versus Usual Voiding to Reduce the Incidence of Urinary Tract Infections in Kidney Transplant Recipients

About This Trial

Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.

Who May Be Eligible (Plain English)

Who May Qualify: - All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic. Who Should NOT Join This Trial: - Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic. Exclusion Criteria: * Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)

Treatments Being Tested

OTHER

Double Voiding

Participant will be instructed to void twice.

OTHER

Regular Voiding

Participant will void as usual

Locations (1)

Weill Cornell Medical College / NY Presbyterian

New York, New York, United States